Found 331 clinical trials
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
The primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely active Crohn's disease (CD) in
- 2243 views
- 08 May, 2018
- 1 location
Induction Study #1 of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Crohn's Disease.
- 62 views
- 15 Sep, 2021
- 69 locations
Induction Study #2 of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Crohn's Disease.
- 0 views
- 15 Sep, 2021
- 69 locations
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of Oral Ozanimod As Induction Therapy For Moderately To Severely Active Crohn’s Disease
active Crohn's Disease. Other studies available to continue treatment later after the initial 12 weeks period.
- 32 views
- 23 Nov, 2020
- 1 location
Ulcerative Colitis (UC) Study at ClinSearch
Ulcerative Colitis (UC) is another form of inflammatory bowel disease (IBS). Unlike Crohn’s, which can affect any part of the digestive tract, UC only affects the colon and rectum.
- 85 views
- 23 Mar, 2022
- 1 location
Do you suffer from Crohn's Disease?"
Do you suffer from Crohn's Disease?"
- 146 views
- 25 Mar, 2021
- 1 location